Cabaletta Bio, Inc. — Director's Dealing 2026

Jan 21, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2026-01-21

Reporting Person: Tomasello Shawn (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-21	Common Stock	P	22725	$2.2144	Acquired	22725	Indirect